Same deal as AXON -- the connected manage to get great deals for drugs that turn out to be overvalued. AXON had the huge IPO because it was started by Wall Street insiders, based entirely on a failed Alzheimer's drug they paid 5 million to acquire. That turned out well for early investors, didn't it? hahaha

http://bigcharts.marketwatch.com/quickchart/q...mp;time=20

Wall Street crooks.